1 |
Rauseo AM, Hink T, Reske KA, Seiler SM, Bommarito KM, Fraser VJ, Burnham CD, Dubberke ER; CDC Prevention Epicenter Program. A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization. Infect Control Hosp Epidemiol 2021;:1-7. [PMID: 33820576 DOI: 10.1017/ice.2021.94] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Abbott IJ, Roberts JA, Meletiadis J, Peleg AY. Antimicrobial pharmacokinetics and preclinical in vitro models to support optimized treatment approaches for uncomplicated lower urinary tract infections. Expert Rev Anti Infect Ther 2021;19:271-95. [PMID: 32820686 DOI: 10.1080/14787210.2020.1813567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Zare M, Vehreschild MJGT, Wagenlehner F. Management of uncomplicated recurrent urinary tract infections. BJU Int 2021. [PMID: 34741796 DOI: 10.1111/bju.15630] [Reference Citation Analysis]
|
4 |
Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, Starkey MR. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol 2021;14:779-92. [PMID: 33542492 DOI: 10.1038/s41385-020-00372-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
5 |
Schiereck T, Yeldan S, Kranz J, Schneidewind L, Wagenlehner F, Wieters I, Vehreschild MJGT, Otto T, Barski D. [Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]. Urologe A 2021. [PMID: 34424357 DOI: 10.1007/s00120-021-01621-6] [Reference Citation Analysis]
|